Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.410
0.00 (0.00%)
Feb 13, 2026, 4:00 PM EST - Market closed
Ocugen Market Cap
Ocugen has a market cap or net worth of $462.32 million as of February 13, 2026. Its market cap has increased by 106.32% in one year.
Market Cap
462.32M
Enterprise Value
462.72M
1-Year Change
106.32%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $462.32M, an increase of 1,311.70%. That is a compound annual growth rate of 51.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 462.32M | 9.65% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 482.32M |
| Solid Biosciences | 482.26M |
| Zevra Therapeutics | 478.53M |
| 4D Molecular Therapeutics | 476.92M |
| Upstream Bio | 472.84M |
| Lexeo Therapeutics | 460.55M |
| DiaMedica Therapeutics | 457.02M |
| Verastem | 449.20M |